The results of the present candidate gene-driven association analysis show that CD5, CD6, and CD166/ALCAM genetic polymorphisms are associated with the clinical and analytical parameters of the disease in a local cohort of pSS patients. Here, CD5 is linked to peeling skin syndrome.